Targeting the CD146/Galectin-9 axis protects the integrity of the blood–brain barrier in experimental cerebral malaria
Open Access
- 17 November 2020
- journal article
- research article
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 18 (10) , 2443-2454
Abstract
Cerebral malaria (CM) is a life-threatening diffuse encephalopathy caused by Plasmodium falciparum, in which the destruction of the blood–brain barrier (BBB) is the main cause of death. However, increasing evidence has shown that antimalarial drugs, the current treatment for CM, do little to protect against CM-induced BBB damage. Therefore, a means to alleviate BBB dysfunction would be a promising adjuvant therapy for CM. The adhesion molecule CD146 has been reported to be expressed in both endothelial cells and proinflammatory immune cells and mediates neuroinflammation. Here, we demonstrate that CD146 expressed on BBB endothelial cells but not immune cells is a novel therapeutic target in a mouse model of experimental cerebral malaria (eCM). Endothelial CD146 is upregulated during eCM development and facilitates the sequestration of infected red blood cells (RBCs) and/or proinflammatory lymphocytes in CNS blood vessels, thereby promoting the disruption of BBB integrity. Mechanistic studies showed that the interaction of CD146 and Galectin-9 contributes to the aggregation of infected RBCs and lymphocytes. Deletion of endothelial CD146 or treatment with the anti-CD146 antibody AA98 prevents severe signs of eCM, such as limb paralysis, brain vascular leakage, and death. In addition, AA98 combined with the antiparasitic drug artemether improved the cognition and memory of mice with eCM. Taken together, our findings suggest that endothelial CD146 is a novel and promising target in combination with antiparasitic drugs for future CM therapies.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7192123)
- National Natural Science Foundation of China (31770793, 31530026)
This publication has 52 references indexed in Scilit:
- Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African childrenBlood, 2013
- To characterize the neurocognitive sequelae of cerebral malaria (CM) in an adult sample of the city of Benguela, AngolaAsian Pacific Journal of Tropical Biomedicine, 2013
- Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNSScientific Reports, 2013
- A Novel Domain Cassette Identifies Plasmodium falciparum PfEMP1 Proteins Binding ICAM-1 and Is a Target of Cross-Reactive, Adhesion-Inhibitory AntibodiesThe Journal of Immunology, 2013
- Brain Swelling and Mannitol Therapy in Adult Cerebral Malaria: A Randomized TrialClinical Infectious Diseases, 2011
- A Rapid Murine Coma and Behavior Scale for Quantitative Assessment of Murine Cerebral MalariaPLOS ONE, 2010
- Adjunctive therapy for cerebral malaria and other severe forms ofPlasmodium falciparummalariaExpert Review of Anti-infective Therapy, 2010
- The murine cerebral malaria phenomenonTrends in Parasitology, 2010
- Adhesion ofPlasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implicationsExpert Reviews in Molecular Medicine, 2009
- N-acetylcysteine as adjunctive treatment in severe malaria: A randomized, double-blinded placebo-controlled clinical trial*Critical Care Medicine, 2009